Cell & Gene Therapy Pricing & Reimbursement Summit is coming to Washington DC on the 25th - 27th June 2024. Unlocking Patient Access to Affordable Advanced Therapies ...

Gene therapies have ridden investor mania to huge valuations but commercialization challenges have pushed market caps to the ...

Over the last 15 years, I have witnessed how cell and gene therapy (CGT) has evolved in many ways, spanning from research and development to manufacturing. Breakthroughs such as CAR-T and gene ...

Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the ...

Gene therapy fixes that problem by giving the patient’s blood-forming cells a new, normal hemoglobin gene. An estimated 100,000 people in the United States, most of them Black, have sickle cell ...

Vertex Pharmaceuticals (NASDAQ:VRTX) announced Friday a reimbursement agreement with England’s National Health Service (NHS) ...